Mical Paul

10PUBLICATIONS
44CO-AUTHORS
Clinical microbiologyMedical bacteriologyPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 03, 2026
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

|Jul 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of People With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens.

Mariya Huralska, Jason M Pogue, Michael Rybak

|Jan 28, 2025
Ceftaroline versus vancomycin for methicillin-resistant Staphylococcus aureus bacteraemia, a matched cohort study.

Roni Bitterman, Aya Awwad, Basel Darawsha

|Jul 02, 2024
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomes.

Vincent Aranzana-Climent, Wisse van Os, Amir Nutman

|Feb 02, 2023
Optimizing patient recruitment into clinical trials of antimicrobial-resistant pathogens.

Mical Paul, Yael Dishon-Benattar, Yaakov Dickstein

|Jun 20, 2022
Is shorter always better? The pros and cons of treating Gram-negative bloodstream infections with 7 days of antibiotics.

Dafna Yahav, Mical Paul, Cees Van Nieuwkoop

Pageof 2

Frequent Collaborators

4 joint publications

Dafna Yahav

2 joint publications

Emanuele Durante-Mangoni

2 joint publications

George L Daikos

1 joint publications

Yanay Porat